Cy5 drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (8)
Papers in which this entity is mentioned.
- Enhancer activation from transposable elements in extrachromosomal DNA. (2025)
- Multigenerational cell tracking of DNA replication and heritable DNA damage. (2025)
- Tracing the evolution of single-cell 3D genomes in Kras-driven cancers. (2025)
- Transient loss of Polycomb components induces an epigenetic cancer fate. (2024)
- Spatially resolved whole transcriptome profiling in human and mouse tissue using Digital Spatial Profiling. (2022)
- A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease. (2016)
- Spatial reconstruction of single-cell gene expression data. (2015)
- Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. (2012)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cy5 | drug | 22 | 28 |